23
Oct
2024

Public Webinar: HTA/Payer National Collaborative Initiatives – The Role of Real-World Evidence

On the 23rd of October, between 15:00-16:30 CEST, RWE4Decisions will be hosting its last webinar for 2024: “HTA/Payer National Collaborative Initiatives – The Role of Real-World Evidence”.


Join us to explore the creation and operation of the Joint Nordic HTA Bodies (JNHB) collaboration, how it evolved from FINOSE to JNHB, and how joint reports are taken up locally.

Make sure to sign up here!

PROGRAMME

15:00

Welcome from the co-moderators

  • Dr Tove Holm-Larsen
    Chief Executive Officer, Silvi.ai / Professor, Ghent University
    Dr Alexander Natz
    Secretary General, European Confederation of Pharmaceutical Entrepreneurs
15:05

Keynote presentations

Joint Nordic HTA Bodies (JNHB) – the Nordics example of collaboration

  • Dr Ehm Astrid Andersson Galijatovic
    Medical Assessor, Chief Consultant, Danish Medicines Council (DMC)
  • Dr Maria Eriksson
    Medical Assessor, Dental and Pharmaceutical Benefits Agency (TLV)
15:25

Panel discussion

  • Prof Kimmo Porkka
    Professor of personalised cancer medicine / Chief physician, University of Helsinki
  • Dr Christian Dehlendorff
    Biostatistical Chief Consultant, Danish Medicines Council (DMC)
  • Lars Møller
    Access & Value FIND Cluster Lead and Managing Director, Pfizer Denmark
16:00

Q&A with audience

16:25

Next steps

16:30

Meeting close

Upcoming Events

More
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
14
Nov
2024
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
09:00-13:00 CET
Hybrid, Brussels
More